Showing 1,221–1,240 of 18,047 drug recalls
Drug Recall
Terminated
Historical record Class II
Kingskin, Elimina Las Verrugas, For the removal of common warts, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-409-15 by Pharmadel, LLC
Reason
cGMP deviations Recall initiated
April 15, 2025 Reported by FDA
April 30, 2025 Distribution
DE
View recall →
Drug Recall
Terminated
Historical record Class II
DoloDent Maximum Strength Toothache Drops, Homeopathic Oral Drops, 0.50 oz fl (15 mL), Distributed by: Pharmadel, New Castle, DE 19720, NDC 55758-400-15 by Pharmadel, LLC
Reason
cGMP deviations Recall initiated
April 15, 2025 Reported by FDA
April 30, 2025 Distribution
DE
View recall →
Drug Recall
Ongoing
Historical record Class II
Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g) tubes, Manufactured by: Apipharma d.o.o, Croatia, Distributed by: Apipharma, LLC, Tempe, AZ UPC 3 858882 103534 and UPC 3 858882 101318 by Apipharma
Reason
CGMP Deviations Recall initiated
April 9, 2025 Reported by FDA
April 30, 2025 Distribution
AZ
View recall →
Drug Recall
Ongoing
Historical record Class II
Rocuronium Bromide 50 mg per 5mL (10mg per mL), 5mL Single Dose Syringe, Rx only, Leiters Health, 13796 Compark Blvd, Englewood, CO 80112. NDC: 71449-004-11 by Denver Solutions, LLC DBA Leiters Health
Reason
Lack of Assurance of Sterility: Leaking/damaged syringes. Recall initiated
March 31, 2025 Reported by FDA
April 30, 2025 Distribution
Nationwide in the U.S.A
View recall →
Drug Recall
Ongoing
Historical record Class II
Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelamangala, Bangalore -562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-581-48. by Amerisource Health Services LLC
Reason
Lack of assurance of sterility. Bacterial contamination detected in some media fill units Recall initiated
April 2, 2025 Reported by FDA
April 30, 2025 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for BluePoint Laboratories, NDC 68001-581-41. by Amerisource Health Services LLC
Reason
Lack of assurance of sterility. Bacterial contamination detected in some media fill units Recall initiated
April 2, 2025 Reported by FDA
April 30, 2025 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41. by Amerisource Health Services LLC
Reason
Lack of assurance of sterility. Bacterial contamination detected in some media fill units Recall initiated
April 2, 2025 Reported by FDA
April 30, 2025 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 TABLETS (10x10), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-7129-61 by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Reason
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit Recall initiated
April 14, 2025 Reported by FDA
April 23, 2025 Distribution
Nationwide USA
View recall →
Drug Recall
Ongoing
Historical record Class I
Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, Manufactured by: Gland Pharma Limited, Hyderabad, - 500 043 INDIA, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, NDC 43598-636-52 by Dr. Reddy's Laboratories, Inc.
Reason
LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL. Recall initiated
March 13, 2025 Reported by FDA
April 23, 2025 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
CIPROFLOXACIN OPHTH SOLUTION, 0.3% 5mL bottle, Rx Only, Generic for CILOXAN, Packaged and Distributed by: DIRECT Rx, NDC 61919-795-05. by Direct Rx
Reason
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle Recall initiated
January 31, 2025 Reported by FDA
April 23, 2025 Distribution
Physicians and medical facilities in 5 states: AL, CA, FL, GA, ID
View recall →
Drug Recall
Ongoing
Historical record Class II
Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01 by Eugia US LLC
Reason
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. Recall initiated
April 10, 2025 Reported by FDA
April 23, 2025 Distribution
Nationwide USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsules bottles, Dist. by Chattem, Inc., P.O. Box 2219, Chattanooga, TN 37409-0219, USA, UPC 0 41167 00670 2 by Chattem Inc
Reason
CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit Recall initiated
March 26, 2025 Reported by FDA
April 23, 2025 Distribution
Nationwide.
View recall →
Drug Recall
Ongoing
Historical record Class II
chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1129-1 by Zydus Pharmaceuticals (USA) Inc
Reason
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit Recall initiated
April 3, 2025 Reported by FDA
April 16, 2025 Distribution
Nationwide within U.S - MS, AL, TN, VT, OH, ND, MN, WI, SC, AR, FL, IN, LA, NJ, AZ, TX, KY and PA
View recall →
Drug Recall
Ongoing
Historical record Class II
Proactiv Skin Smoothing Exfoliator (Benzoyl Peroxide 2.5%), Packaged as a) 6 fl. oz. (177.4 mL), UPC 7 35786 01528 2; b) 0.33 OZ (9.45g), UPC 8 42944 10223 1; Distributed by Alchemee, LLC, Santa Monica, CA 90401, by Alchemee, LLC
Reason
Chemical contamination: Presence of benzene Recall initiated
March 12, 2025 Reported by FDA
April 16, 2025 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Proactiv Emergency Blemish Relief (Benzoyl Peroxide 5%), 0.33 oz. (9.45 g), Distributed by Alchemee LLC, Santa Monica, CA 90401, Made in the USA, UPC 7 35786 01921 1, UPC 8 42944 10223 1, and also packaged as a twin pack UPC 8 42944 10241 5, by Alchemee, LLC
Reason
Chemical contamination: Presence of benzene Recall initiated
March 12, 2025 Reported by FDA
April 16, 2025 Distribution
Nationwide in the USA
View recall →
Drug Recall
Ongoing
Historical record Class II
Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10 by Somerset Therapeutics Private Limited
Reason
Lack of Assurance of Sterility: Media fill with bacterial contamination Recall initiated
March 21, 2025 Reported by FDA
April 16, 2025 Distribution
U.S. Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons) by Somerset Therapeutics Private Limited
Reason
Lack of Assurance of Sterility: Media fill with bacterial contamination Recall initiated
March 21, 2025 Reported by FDA
April 16, 2025 Distribution
U.S. Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41 by Somerset Therapeutics Private Limited
Reason
Lack of Assurance of Sterility: Media fill with bacterial contamination Recall initiated
March 21, 2025 Reported by FDA
April 16, 2025 Distribution
U.S. Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-381-01 (individual carton) and NDC 70069-381-10 (10x1 mL carton) by Somerset Therapeutics Private Limited
Reason
Lack of Assurance of Sterility: Media fill with bacterial contamination Recall initiated
March 21, 2025 Reported by FDA
April 16, 2025 Distribution
U.S. Nationwide
View recall →
Drug Recall
Ongoing
Historical record Class II
Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton) by Somerset Therapeutics Private Limited
Reason
Lack of Assurance of Sterility: Media fill with bacterial contamination Recall initiated
March 21, 2025 Reported by FDA
April 16, 2025 Distribution
U.S. Nationwide
View recall →
Data last updated: October 31, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .
